We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

021240:KRXCoway Co., Ltd. Analysis

Data as of 2026-09-01 - not real-time

₩97,800.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind COWAY Co., Ltd. is bullish at KRW 97,800.00, with short-term averages leading the long-term ones. Relative strength is 52.5 — neutral — and the MACD signal is bullish. Price has been bracketed by support at KRW 88,800.00 and resistance at KRW 101,700.00.
Valuation screens as undervalued, on a P/E of 8.8 with no clean sector comparison available. The average analyst target implies 28.5% above today's level. Revenue is growing at 14.6% on a 12.9% profit margin. The 3.46% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 32.7%, a beta of 0.32 and a maximum drawdown of 34.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 8/10 conviction.

Top Market Events

media 1167965 SEOUL, South Korea, Aug. 7, 2026 /PRNewswire/ -- Coway Co., Ltd., the 'Best Life Solution Company,'...SEOUL, South Korea, Aug. 7, 2026 /PRNewswire/ -- Coway Co., Ltd., the "Best Life Solution Company," announced its...SEOUL, South Korea, Aug. 3, 2026 /PRNewswire/ -- Coway Co., Ltd., the "Best Life Solution Company," has published its...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 86361.00
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 86361.00
  • Analyst targets imply +28.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst targets imply +28.5% versus the current price
  • Revenue growth of +14.6%
  • P/E ratio of 8.8

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin12.89%
P/E Ratio8.8
ROE19.31%
ROA8.23%
Debt/Equity69.92
Op. Cash Flow₩-3312315648
Free Cash Flow₩381.3B

Technical Analysis

TrendBullish
RSI52.5
Support₩88,800.00
Resistance₩101,700.00
MA 20₩96,290.00
MA 50₩93,320.00
MA 200₩86,361.00
MACDBullish
VolumeDecreasing
Fear & Greed Index92.7

Valuation

Fair Value₩90,796.50
Target Price₩125,700.00
Upside/Downside28.53%
GradeUndervalued
TypeValue
Dividend Yield3.46%

Risk Assessment

Beta0.32
Volatility32.67%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.